Moderna raises full-year COVID vaccine sales forecast to $21 billion

Moderna Inc raised its full-year forecast for sales of its COVID-19 vaccine to roughly $21 billion from $19 billion. The company in February forecast sales of $19 billion from its signed contracts, and option for $3 billion in additional purchases. Moderna on Thursday forecast additional purchases of roughly $500 million.